No description available.

This study examined the relationship between music therapists' spiritual beliefs and their clinical practices. A survey was sent to 4243 members of the Certification Board for Music Therapy, using an electronic program, SurveyMonkey. There was a return rate of 32%. The survey contained two parts; Part I was the Music Therapy Questionnaire, and Part II was the Spiritual Involvement and Beliefs Scale (SIBS). Data were analyzed using a combination of Kruskal-Wallis Anova, Mann-Whitney U, and Spearman Rho correlation tests to analyze both the relationships as well as significant variations in responses between the survey questions and the SIBS scores. Research questions focused on the relationships between the music therapists' spirituality scores (SIBS) and their demographics, their reported spiritual beliefs and practices, and their clinical practices. Statistical analyses revealed significant differences in the relationship between SIBS scores and gender, age, and years of professional experience; however, there were no significant differences between SIBS scores and education level, regions of AMTA, or client populations served. Significant correlations were found between SIBS scores and music therapists' personal appraisal of their own spirituality, their use of music as a spiritual experience, the use of music in their own personal practice, and their belief in the importance of some type of contemplative experience in their own personal lives. Further statistical analyses also revealed significant correlations between music therapists' SIBS scores and the following clinical practices: 1) the role of spirituality as a sustaining force in their music therapy career, 2) their spiritual ideals as exemplified in their work, 3) attention to their own spirituality in their role as a music therapist, 4) their spiritual growth as a music therapist, 5) the classifying of their work as a spiritual endeavor, 6) their choice of music therapy as a profession. Additional positive correlations were found between music therapists' SIBS scores and the reported influence of spirituality on their choice of population, their comfort in addressing clients' spiritual needs when they are similar to their own, and their comfort in addressing clients' spiritual needs when they are different from their own. / Music Therapy

Background: Physical activity (PA) is an important component of a healthy pregnancy and has consistently been associated with improved weight management and a reduced risk of pregnancy complications. While the percentage of pregnant women meeting PA guidelines internationally is alarmingly low, no such data exists for the Canadian population. PA in pregnancy may also be a useful intervention for preventing and managing cardiometabolic dysfunction, but research in pregnancy is limited. Objectives: 1) To describe the PA and exercise habits of women in early pregnancy and assess the percentage of women meeting SOGC/CSEP guidelines for exercise in pregnancy; 2) To determine the association of PA with maternal cardiometabolic health in early pregnancy. Study Design: Maternal blood samples, and PA, dietary, and adiposity measures were collected from a subset of women in early pregnancy (12 – 17 wk gestation) upon enrollment in the Be Healthy in Pregnancy RCT. Fasted blood samples were analyzed for glucose, triglycerides, insulin, leptin, adiponectin and C-reactive protein (CRP). Self-reported and objectively measured PA were assessed using the PARmed-X for Pregnancy and an accelerometer. PA was quantified by three parameters: daily step count, energy expenditure (kcal/day) and meeting the SOGC/CSEP recommendations. Results: For the 198 participants of age 31 ± 4 years; BMI 25.4 ± 4.7kg/m2; at 13 ± 2 wk gestation (mean ± SD), 19.2% reported not exercising in early pregnancy. Approximately half of participants met the minimum SOGC/CSEP recommendation (15 min, 3x/wk), but only 14.2% met the preferred SOGC/CSEP recommendation (30 min, 4x/wk). Meeting the preferred recommendation was associated with lower CRP. Daily step count and energy expenditure (kcal/day) were not significantly associated with glucose, triglycerides, insulin, leptin, adiponectin or CRP. Percent body fat and a higher diet quality were associated with some of the cardiometabolic biomarkers. Conclusion: In a healthy pregnant cohort, while the majority had PA below recommendations, measured PA was not associated with most cardiometabolic biomarkers thus cardiometabolic risk in early pregnancy was low. / Thesis / Master of Science (MSc)

For over half a century, it has been widely known that lithium is the most efficacious treatment for bipolar disorder. Yet, despite this, its prescription has consistently declined over this same period of time. A number of reasons for this apparent disparity between evidence and clinical practice have been proposed, including a lack of confidence amongst clinicians possibly because of an absence of training and lack of familiarity with the molecule. Simultaneously, competition has grown within the pharmacological armamentarium for bipolar disorder with newer treatments promoting an image of being safer and easier to prescribe primarily because of not necessitating plasma monitoring, which understandably is appealing to patients who then exercise their preferences accordingly. However, these somewhat incipient agents are yet to reach the standard lithium has attained in terms of its efficacy in providing prophylaxis against the seemingly inevitable recrudescence of acute episodes that punctuates the course of bipolar disorder. In addition, none of these mimics have the additional benefits of preventing suicide and perhaps providing neuroprotection. Thus, a change in strategy is urgently required, wherein myths regarding the supposed difficulties in prescribing lithium and the gravity of its side-effects are resolutely dispelled. It is this cause to which we have pledged our allegiance and it is to this end that we have penned this article.

Problématique : L’arrivée des tests de pharmacogénétique a été annoncée dans les médias et la littérature scientifique telle une révolution, un tournant vers la médecine personnalisée. En réalité, cette révolution se fait toujours attendre. Plusieurs barrières législatives, scientifiques, professionnelles et éthiques sont décrites dans la littérature comme étant la cause du délai de la translation des tests de pharmacogénétique, du laboratoire vers la clinique. Cet optimisme quant à l’arrivée de la pharmacogénétique et ces barrières existent-elles au Québec? Quel est le contexte de translation des tests de pharmacogénétique au Québec? Actuellement, il n’existe aucune donnée sur ces questions. Il est pourtant essentiel de les évaluer. Alors que les attentes et les pressions pour l’intégration rapide de technologies génétiques sont de plus en plus élevées sur le système de santé québécois, l’absence de planification et de mécanisme de translation de ces technologies font craindre une translation et une utilisation inadéquates. Objectifs : Un premier objectif est d’éclairer et d’enrichir sur les conditions d’utilisation et de translation ainsi que sur les enjeux associés aux tests de pharmacogénétique dans le contexte québécois. Un deuxième objectif est de cerner ce qui est véhiculé sur la PGt dans différentes sources, dont les médias. Il ne s’agit pas d’évaluer si la pharmacogénétique devrait être intégrée dans la clinique, mais de mettre en perspective les espoirs véhiculés et la réalité du terrain. Ceci afin d’orienter la réflexion quant au développement de mécanismes de translation efficients et de politiques associées. Méthodologie : L’analyse des discours de plusieurs sources documentaires (n=167) du Québec et du Canada (1990-2005) et d’entretiens avec des experts québécois (n=19) a été effectuée. Quatre thèmes ont été analysés : 1) le positionnement et les perceptions envers la pharmacogénétique; 2) les avantages et les risques reliés à son utilisation; 3) les rôles et les tensions entre professionnels; 4) les barrières et les solutions de translation. Résultats : L’analyse des représentations véhiculées sur la pharmacogénétique dans les sources documentaires se cristallise autour de deux pôles. Les représentations optimistes qui révèlent une fascination envers la médecine personnalisée, créant des attentes (« Génohype ») en regard de l’arrivée de la pharmacogénétique dans la clinique. Les représentations pessimistes qui révèlent un scepticisme (« Génomythe ») envers l’arrivée de la pharmacogénétique et qui semblent imprégnés par l’historique des représentations médiatiques négatives de la génétique. Quant à l’analyse des entretiens, celle-ci a permis de mettre en lumière le contexte actuel du terrain d’accueil. En effet, selon les experts interviewés, ce contexte comporte des déficiences législatives et un dysfonctionnement organisationnel qui font en sorte que l’utilisation des tests de pharmacogénétique est limitée, fragmentée et non standardisée. S’ajoute à ceci, le manque de données probantes et de dialogue entre des acteurs mal ou peu informés, la résistance et la crainte de certains professionnels. Discussion : Plusieurs changements dans la réglementation des systèmes d’innovation ainsi que dans le contexte d’accueil seront nécessaires pour rendre accessibles les tests de pharmacogénétique dans la pratique clinique courante. Des mécanismes facilitateurs de la translation des technologies et des facteurs clés de réussite sont proposés. Enfin, quelques initiatives phares sont suggérées. Conclusion : Des efforts au niveau international, national, provincial et local sont indispensables afin de résoudre les nombreux obstacles de la translation des tests de pharmacogénétique au Québec et ainsi planifier l’avenir le plus efficacement et sûrement possible. / Problematic: The advent of pharmacogenetic testing was heralded in the media and in scientific literature as a revolution and the dawn of a new era of personalized medicine. This revolution has yet to arrive. The literature describes several legislative, scientific, professional and ethical barriers that are causing a delay in the translation of pharmacogenetic testing into clinical practice. In Quebec, is there optimism about pharmacogenetics and do these barriers exist? And in what context is the integration of pharmacogenetic testing taking place? At present, these questions remain unanswered. Yet they are of critical importance. While there are growing expectations and pressure on the Quebec health system to rapidly incorporate genetic technology, the lack of planning and of mechanisms for the translation of this technology may jeopardize its adequate transfer and use. Objectives: The first objective was to gain clearer and fuller insight and understanding into the conditions of use and translation of pharmacogenetic testing in Quebec and its related issues. The second was to identify the message being conveyed about pharmacogenetics in various sources, including the media. The issue at hand was not whether pharmacogenetics should or should not be integrated into clinical practice, but rather to put into perspective the hopes being set forth regarding pharmacogenetics and the realistic nature of the enterprise. The purpose of the exercise was to provide a framework for thinking about the development of efficient translation mechanisms and the policies associated with it. Methodology: Discourse analyses of several documentary sources (n=167) in Quebec and Canada (1990-2005) and interviews with Quebec experts (n=19) were conducted. Four themes were explored: 1) the positioning and perception of pharmacogenetics; 2)the advantages and risks associated with its use; 3) the roles of various professionals and the tensions that exist among them; 4) the barriers and solutions to translation. Results: Analysis of the representations of pharmacogenetics in the documentary sources revealed a divide between two distinct poles. On the one hand, the optimistic representations showed a fascination with personalized medicine, creating expectations (“Genohype”) regarding the introduction of pharmacogenetics to the clinical setting. On the other hand, the highly sceptical pessimistic representations (“Genomyth”) of pharmacogenetics seemed to be permeated by the history of negative media representations of genetics. Furthermore, analyses of the interviews shed light on the current social, political and clinical context. In fact, according to the experts interviewed, this context is characterized by legislative shortcomings and a dysfunctional organizational structure, which have led to a limited, fragmented and non-standardized use of pharmacogenetic testing. Added to this is a lack of clinical data, an absence of communication among various ill-informed or uninformed players and both resistance and fear among certain professionals. Discussion: Many regulatory changes to the innovation system and current context are needed to ensure access to pharmacogenetic testing in the present clinical setting. Mechanisms to facilitate the translation of technology and the key factors needed for success are also described. Finally, several flagship initiatives are suggested. Conclusion: International, national, provincial and local efforts are required to overcome the various barriers to the translation of pharmacogenetic testing into clinical practice in Quebec and thus plan the future in the safest, most efficient manner possible.

Suite aux notifications de cas de comportements suicidaires associés aux antidépresseurs (ADs) chez les jeunes, une mise en garde réglementaire a été émise en mai 2004 au Canada, et deux guides de pratique clinique ont été publiés dans la littérature en novembre 2007. L'objectif de ce mémoire fut d'évaluer l’association entre ces interventions de communication et le suivi médical de la population pédiatrique traitée par ADs au Québec. Une étude de cohorte rétrospective (1998-2008) a été menée chez 4 576 enfants (10-14 ans) et 12 419 adolescents (15-19 ans) membres du régime public d’assurance médicaments du Québec, ayant débuté un traitement par AD. Le suivi médical dans les trois premiers mois de traitement a été mesuré par l’occurrence et la fréquence de visites médicales retrouvées dans les banques de données de la RAMQ. Les facteurs associés à un suivi conforme aux recommandations ont été évalués à partir de modèles de régression logistique multivariés. Seuls 20% des enfants ou adolescents ont eu au moins une visite de suivi à chaque mois, en conformité avec les recommandations. La probabilité de recevoir un suivi médical conforme était plus élevée lorsque le prescripteur initial était un psychiatre. L’occurrence et la fréquence des visites n’ont pas changé après la publication de la mise en garde ou des recommandations. De ce mémoire on conclut que d'autres interventions visant à optimiser le suivi médical devraient être envisagées. / Following reports of a potential association between antidepressants (ADs) and suicidal behaviour in youth, a regulatory warning was issued in Canada in May 2004, and clinical practice guidelines on recommended medical follow-up were published in the literature in November 2007. This Master's thesis aimed at assessing the association between these communication interventions and medical follow-up practices. A retrospective cohort study (1998-2008) was conducted among 4,576 children (10-14 years) and 12,419 adolescents (15-19 years) members of the Quebec public drug plan. Medical follow-up was ascertained through patterns of physician billing practices found in the RAMQ medical services databases. Study outcomes consisted of occurrence and frequency of visits in the first three months of AD treatment. Factors associated with follow-up consistent with recommendations were identified through multivariate logistic regression models. The main independent variable was exposure to each of the communication interventions. Covariates included: gender, class of AD, number of concomitant chronic diseases, psychiatric conditions, prescriber’s specialty, and potential exposure to each intervention. Only 20% of children or adolescents received at least one visit each month. The probability of receiving adequate follow-up was greater when treatment was initiated by a psychiatrist. Occurrence and frequency of visits did not change after the warning nor the publication of the recommendations. From this thesis, one may conclude that further interventions to optimize medical follow-up practices should be envisaged.

Cette thèse porte sur les représentations sociales de la pharmacogénomique (PGx) chez deux groupes d’acteurs centraux du développement et des applications en PGx au Québec. L’objectif est de comprendre comment les chercheurs en PGx et les étudiants en médecine se positionnent à l’égard des découvertes en PGx et de leurs éventuelles applications en pratique médicale. Cette étude a aussi pour objectifs de mieux comprendre comment il est possible d’anticiper l’arrivée de la PGx dans la pratique médicale par le contraste des représentations des chercheurs et des étudiants et de concevoir comment les informations circulent entre les deux groupes. Pour atteindre ces objectifs, l’utilisation du cadre théorique des représentations sociales, et plus particulièrement des représentations sociales dites professionnelles, est retenue. Une démarche multiméthodologique est déterminée pour cerner les représentations des deux groupes. En effet, une approche qualitative par entretiens semi-dirigés est réalisée dans un premier temps auprès des chercheurs et, ensuite, une enquête par questionnaire est effectuée auprès des étudiants en médecine. Les positionnements des deux groupes sont contrastés au sujet de trois concepts clés : les médicaments, la génomique et la PGx. Les principes organisateurs des représentations sociales des étudiants en médecine et des chercheurs, eu égard à ces trois concepts, permet de positionner le niveau des représentations sociales des étudiants en médecine vers leur professionnalisation dans un schéma proposé par Bataille (2000). Ainsi, les étudiants en médecine fournissent des représentations des médicaments assez près de celles des chercheurs. Leurs représentations des avancées en génomique sont beaucoup moins professionnalisées, tandis que l’on remarque une organisation restreinte pour ce qui est de leur représentation de la PGx. Le contexte de formation médicale est interrogé dans cette thèse puisqu’il laisse peu de place aux découvertes et aux recherches de pointe. Les chercheurs autant que les étudiants affirment que la solution pour améliorer leurs connaissances dans le domaine de la PGx est d’ajouter ces connaissances dans leur cadre de leur formation médicale. / This thesis pertains to social representations of pharmacogenomics (PGx) in two groups of central actors in PGx development and application in Québec. The objective is to understand how PGx researchers and medical students stand with regard to PGx discoveries and their potential medical practice applications. This study also aims at better understanding how the arrival of PGx in medical practice can be anticipated, by contrasting researchers’ and students’ representations, and at grasping how the information flows between these two groups. To meet these objectives, the theoretical framework of social representations, and more particularly the so-called professional social representations, is used. The two groups’ representations are identified through a multi method approach. Indeed, a qualitative method consisting of semi-structured interviews with the researchers is used, followed by a questionnaire survey of the medical students. The two groups’ positions are compared with respect to three key concepts: medication, genomics and PGx. The organizing principles of the medical students’ and researchers’ social representations, in consideration of these three concepts, enables us to position the social representation levels of the medical students relative to their professionalization in a chart proposed by Bataille (2000). The medical students’ representations of medication are thus similar to those of the researchers. Their representations of advances in genomics are far less professionalized, while there is an absence of organization in their representation of PGx. The medical training context is questioned in this thesis since it leaves little room for discovery and advanced research. Researchers and students both say that the solution for improving their knowledge in the field of PGx is to make it part of their medical training.

La lombalgie compte parmi les causes principales d’incapacité chez des membres des Forces armées canadiennes (FAC). Une prise en charge efficace de cette condition est donc primordiale afin de maintenir des forces opérationnelles. Les études randomisées contrôlées réalisées auprès de la population générale suggèrent que la direction préférentielle (DP) est efficace pour guider la prise en charge de la lombalgie. Toutefois, aucune étude n’a investigué l’efficacité d’une telle approche en contexte réel ou auprès de la population militaire. L’objectif de ce mémoire était d’évaluer, dans le contexte réel de la pratique clinique, l’efficacité d’une prise en charge guidée par la DP parmi des membres des FAC souffrant de lombalgie. Pour ce faire, une étude observationnelle de cohorte incluant 44 membres consentant des FAC a été réalisée. Les patients du groupe exposé (n=22) ont reçu des interventions guidées par la DP. Les patients du groupe non-exposé (n=22) ont reçu les soins usuels, soit des interventions déterminées par leur physiothérapeute, mais pas d’approche guidée par la DP. Les données ont été colligées et comparées entre les deux groupes au début de l’étude, à 1 mois, et à 3 mois grâce à un questionnaire autoadministré concernant la douleur (intensité, localisation, fréquence), l’incapacité perçue, la consommation de médicaments, et l’effet global perçu (douleur, fonctionnement et état général). La perte de productivité et l’utilisation de soins de santé ont été mesurées à 3 mois grâce au dossier médical électronique. Des différences statistiquement significatives en faveur du groupe exposé à une prise en charge guidée par la DP ont été observées pour l’intensité de la douleur (Δ à 1 mois : 1,9/10; Δ à 3 mois : 1,3/10), l’incapacité perçue (Δ 1 mois : 4,3/24; Δ 3 mois : 3,5/24), l’amélioration de l’effet global perçu à 1 mois (douleur : 86,4 % vs 57,1 %; fonctionnement : 81,8 % vs 47,6 %; état général : 86,4 % vs 57,1 %) et à 3 mois (douleur : 95,5 % vs 71,1 %; état général : 95,5 % vs 66,7 %), et l’amélioration du statut au travail à 3 mois (54,5 % vs 23,8 %). Malgré les limites de notre étude, nos résultats suggèrent qu’en conditions réelles de pratique, la prise en charge guidée par la DP est plus efficace que les soins usuels pour réduire la douleur et l’incapacité chez les membres des FAC souffrant de lombalgie. / Abstract : Low back pain (LBP) is a leading cause for disability in Canadian Armed Forces (CAF) members. Efficacious and cost-effective management for LBP is thus essential to maintaining operational capabilities. In randomized controlled trials among the general population, directional preference (DP) was shown useful to guide treatment of LBP, but no studies have investigated this in real-life settings or in military personnel. The purpose of this study was to evaluate, in real-life clinical practice, the effectiveness of DP to guide management of LBP in CAF members when compared to usual care. To that purpose, we conducted a cohort study including 44 consenting CAF members with LBP. Patients in the exposed group (n=22) were assessed for DP and received matching interventions. Patients in the non-exposed group (n=22) received interventions as determined by their treating physiotherapist, excluding any DP-guided treatments. Data were collected and compared between groups at baseline, at 1-month and at 3-month follow-up using self-administered questionnaires regarding pain (intensity, location, frequency), perceived disability, medication, and perceived global effect (pain, function, overall status). Work loss and health care utilization were measured at 3 months using electronic health records. Statistically significant differences, favoring the exposed group, were observed for pain intensity (Δ at 1 month: 1.9/10; CI 95%; 0.97 – 2.89; Δ at 3 months: 1.3/10; CI 95%: 0.35 – 2.31), disability (Δ at 1 month: 4.3/24; CI 95%: 2.12 – 6.38; Δ at 3 months: 3.5/24; CI 95%; 1.59 – 5.33), perceived global effect at 1 month (pain: 86.4% vs 57.1%; function: 81.8% vs 47.6%; overall status: 86.4% vs 57.1%) and at 3 months (pain: 95.5% vs 71.1%; overall status: 95.5% vs 66.7%) with p-values <.05, and improvement in work status (3 months: 54.5% vs 23.8%). Our data suggest that DP-guided management is more effective than usual care physiotherapy to reduce pain and improve function in CAF members with LBP. Our findings are useful to inform clinicians and policy makers to improve management strategies for CAF members.

INTRODUÇÃO: O modelo \'prática baseada em evidência na tecnologia assistiva\', possui como objetivo agregar os objetivos dos clientes integrando a experiência dos profissionais às melhores evidências disponíveis da pesquisa sistemática para a escolha do produto. Para o campo da tecnologia assistiva (TA), isso implica uma ênfase na pesquisa de resultados que discute sobre as contribuições dos dispositivos e os serviços relacionados à vida diária dos usuários. No Brasil, existe uma falta de modelos que articulem o uso da TA, diminuindo o abandono dos dispositivos. Com os modelos e os instrumentos de medida, é possível obter dados, comparar os resultados entre populações distintas, adquirir medidas de resultado confiáveis e válidas, de forma econômica e eficaz, e transformar medidas subjetivas em dados objetivos, que podem ser quantificados e analisados. Isso possibilita que se verifiquem os impactos nos processos de intervenção em saúde e se comparem os produtos com menos recursos financeiros. OBJETIVO: Este estudo tem dois objetivos distintos, mas que se entrelaçam ao dar suporte à sua justificativa e que aqui são chamados de Fase A e Fase B. O primeiro, consiste em identificar através da realização de uma revisão sistemática da literatura os diferentes questionários utilizados para selecionar itens de TA. O segundo, realizar o processo de adaptação transcultural do quadro de estruturação para a modelagem conceitual de resultados de dispositivos de TA (QEMCRDTA) para ser utilizado no Brasil. MÉTODO: Para selecionar e escolher o modelo utilizado nesta pesquisa, visando alcançar os objetivos descritos, foram efetuados dois estudos, divididos aqui em fase A e B. Na Fase A, procedeu-se a uma revisão sistemática da literatura nacional e internacional, com o objetivo de identificar os diferentes questionários utilizados para selecionar itens de TA, descrever e avaliar os procedimentos adotados para fazer a adaptação transcultural, com as características e os domínios temáticos de cada artigo, avaliar o processo de adaptação cultural adotado e descrever as propriedades psicométricas encontradas nos trabalhos. A Fase B compreendeu as etapas de: 1) tradução/síntese das traduções; 2) retrotradução (back translation); 3) Análise pelo comitê de especialistas; 4) Teste da versão pré-final conforme diretrizes internacionais. CONCLUSÕES: Os resultados da fase A mostraram que dentre os 560 artigos encontrados, Apenas 05 pesquisas foram incluídas na síntese qualitativa atendendo os critérios de inclusão. O QUEST pode ser considerado o instrumento mais traduzido e adaptado para outras culturas. Os achados da Fase B, expõem um alto índice da validade do conteúdo certificando a qualidade dos itens que representam o conceito mensurado. Todos os itens que passaram pelo processo de adaptação transcultural foram classificados como de fácil entendimento e nenhum item foi acrescentado ou retirado do Quadro de Estruturação para a Modelagem Conceitual de Resultados de Dispositivos de TA (QEMCRDTA) / INTRODUCTION: The model is based on assistive technology, whose main objective is to choose the professionals for the best results of the systematic research to choose the product. For the TA field, this implies an emphasis on researching results on applications and services related to users\' daily life. In Brazil, there is a lack of models that address the use of assistive technology, reducing the abandonment of devices. With models and measuring instruments, it is possible to obtain data, to compare results between distinctions, to obtain expected and variable measures of results, on a temporary and efficient basis, and to carry out the application of objective data, which can be quantified and analyzed. This enables the results of health and health process studies to be compared with other financial resources. PURPOSE: This study has two distinct objectives, but they are intertwined with support for its justification and are called Phase A and Phase B. The first is to identify through the systematic review of the literature the different questionnaires used to select Assistive Technology items. The second was the process of cross-cultural adaptation of the framework for a conceptual modeling of assistive technology resources for use in Brazil. METHOD: To obtain the number of sequential actions, the index was corrected in two years, divided into two years, divided into stages A and B. In Phase A, a systematic review of the national and international literature was carried out, with the Abstract Keywords of different questions for users to change such as trends, the as described and assessor of the evaluation of adaptive studies to discover the cross-cultural characteristics, and the psychiatric strategies processes to adaptability in the works. Phase B comprised the steps of: 1) translation / synthesis of translations; 2) back translation (reverse translation); 3) Analysis by the committee of experts; 4) Testing the pre-final relationship according to international guidelines. CONCLUSIONS: the results of the phase A change that are among the 560 articles found, only 05 were inserted in the qualitative synthesis in proposing inclusion. QUEST can be considered the most translated and adapted instrument for other cultures. The findings of Phase B, expose a high index of content validity, certifying the quality of the items that represent the concept measured. All cases that received the cross-cultural adaptation process were classified as easy to understand and no item was included or removed from the Structuring Framework for a Conceptual Modeling of Assistive Technology Devices Results

INTRODUÇÃO: O modelo \'prática baseada em evidência na tecnologia assistiva\', possui como objetivo agregar os objetivos dos clientes integrando a experiência dos profissionais às melhores evidências disponíveis da pesquisa sistemática para a escolha do produto. Para o campo da tecnologia assistiva (TA), isso implica uma ênfase na pesquisa de resultados que discute sobre as contribuições dos dispositivos e os serviços relacionados à vida diária dos usuários. No Brasil, existe uma falta de modelos que articulem o uso da TA, diminuindo o abandono dos dispositivos. Com os modelos e os instrumentos de medida, é possível obter dados, comparar os resultados entre populações distintas, adquirir medidas de resultado confiáveis e válidas, de forma econômica e eficaz, e transformar medidas subjetivas em dados objetivos, que podem ser quantificados e analisados. Isso possibilita que se verifiquem os impactos nos processos de intervenção em saúde e se comparem os produtos com menos recursos financeiros. OBJETIVO: Este estudo tem dois objetivos distintos, mas que se entrelaçam ao dar suporte à sua justificativa e que aqui são chamados de Fase A e Fase B. O primeiro, consiste em identificar através da realização de uma revisão sistemática da literatura os diferentes questionários utilizados para selecionar itens de TA. O segundo, realizar o processo de adaptação transcultural do quadro de estruturação para a modelagem conceitual de resultados de dispositivos de TA (QEMCRDTA) para ser utilizado no Brasil. MÉTODO: Para selecionar e escolher o modelo utilizado nesta pesquisa, visando alcançar os objetivos descritos, foram efetuados dois estudos, divididos aqui em fase A e B. Na Fase A, procedeu-se a uma revisão sistemática da literatura nacional e internacional, com o objetivo de identificar os diferentes questionários utilizados para selecionar itens de TA, descrever e avaliar os procedimentos adotados para fazer a adaptação transcultural, com as características e os domínios temáticos de cada artigo, avaliar o processo de adaptação cultural adotado e descrever as propriedades psicométricas encontradas nos trabalhos. A Fase B compreendeu as etapas de: 1) tradução/síntese das traduções; 2) retrotradução (back translation); 3) Análise pelo comitê de especialistas; 4) Teste da versão pré-final conforme diretrizes internacionais. CONCLUSÕES: Os resultados da fase A mostraram que dentre os 560 artigos encontrados, Apenas 05 pesquisas foram incluídas na síntese qualitativa atendendo os critérios de inclusão. O QUEST pode ser considerado o instrumento mais traduzido e adaptado para outras culturas. Os achados da Fase B, expõem um alto índice da validade do conteúdo certificando a qualidade dos itens que representam o conceito mensurado. Todos os itens que passaram pelo processo de adaptação transcultural foram classificados como de fácil entendimento e nenhum item foi acrescentado ou retirado do Quadro de Estruturação para a Modelagem Conceitual de Resultados de Dispositivos de TA (QEMCRDTA) / INTRODUCTION: The model is based on assistive technology, whose main objective is to choose the professionals for the best results of the systematic research to choose the product. For the TA field, this implies an emphasis on researching results on applications and services related to users\' daily life. In Brazil, there is a lack of models that address the use of assistive technology, reducing the abandonment of devices. With models and measuring instruments, it is possible to obtain data, to compare results between distinctions, to obtain expected and variable measures of results, on a temporary and efficient basis, and to carry out the application of objective data, which can be quantified and analyzed. This enables the results of health and health process studies to be compared with other financial resources. PURPOSE: This study has two distinct objectives, but they are intertwined with support for its justification and are called Phase A and Phase B. The first is to identify through the systematic review of the literature the different questionnaires used to select Assistive Technology items. The second was the process of cross-cultural adaptation of the framework for a conceptual modeling of assistive technology resources for use in Brazil. METHOD: To obtain the number of sequential actions, the index was corrected in two years, divided into two years, divided into stages A and B. In Phase A, a systematic review of the national and international literature was carried out, with the Abstract Keywords of different questions for users to change such as trends, the as described and assessor of the evaluation of adaptive studies to discover the cross-cultural characteristics, and the psychiatric strategies processes to adaptability in the works. Phase B comprised the steps of: 1) translation / synthesis of translations; 2) back translation (reverse translation); 3) Analysis by the committee of experts; 4) Testing the pre-final relationship according to international guidelines. CONCLUSIONS: the results of the phase A change that are among the 560 articles found, only 05 were inserted in the qualitative synthesis in proposing inclusion. QUEST can be considered the most translated and adapted instrument for other cultures. The findings of Phase B, expose a high index of content validity, certifying the quality of the items that represent the concept measured. All cases that received the cross-cultural adaptation process were classified as easy to understand and no item was included or removed from the Structuring Framework for a Conceptual Modeling of Assistive Technology Devices Results